
Senators Amy Klobuchar, Elizabeth Warren, and five other Democratic senators urged the Justice Department to be cautious in reviewing Google’s planned purchase of Fitbit, saying the tech giant had already cemented its dominance in some areas through acquisitions, reported Reuters.
In a letter to Attorney General William Barr, the seven Democratic senators expressed skepticism that the purchase was solely a bid to enter the wearables market since Google’s revenues are largely based on advertising driven by consumer data.
“Adding Fitbit’s consumer data to Google’s could further diminish the ability of companies to compete with Google in … ad technology markets and could raise barriers for potential competitors to enter these markets,” the lawmakers wrote.
Warren and Klobuchar, the top Democrat on the Senate Judiciary Committee’s antitrust panel, have both been outspoken on antitrust issues. They were joined on the letter by Senators Richard Blumenthal, Cory Booker, Mazie Hirono, Sherrod Brown, and Mark Warner.
The lawmakers also noted that Google had formally told European antitrust enforcers that it would not use Fitbit’s health data to help it target ads. The senators called the offer “modest, short-term concessions.”
Fitbit’s fitness trackers and other devices monitor users’ daily steps, calories burned, and distance traveled. They also measure floors climbed, sleep duration and quality, and heart rate.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas